MAPT and Parkinson disease: We know from our previous studies that experimental and human PD are associated with loss of dopaminergic phenotype in nigrostriatal neurons and believed, at the time, that this down-regulation was associated with α-syn.19–21 Based upon the data described here, we now hypothesize that this down-regulation can also be tau dependent.